Fingerprint
Dive into the research topics of 'Phase II trial of neoadjuvant docetaxel and gefitinib followed by radical prostatectomy in patients with high-risk, locally advanced prostate cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically